Faculty Opinions recommendation of Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

High Efficacy ◽

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials

Clinical Infectious Diseases ◽

10.1093/cid/ciw496 ◽

2016 ◽

Vol 63 (8) ◽

pp. 1042-1048 ◽

Cited By ~ 35

Author(s):

Zobair M. Younossi ◽

Maria Stepanova ◽

Mark Sulkowski ◽

Graham R. Foster ◽

Nancy Reau ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

High Efficacy ◽

High efficacy is accompanied with substantial gains in patient reported outcomes in cirrhotic patients with chronic hepatitis C treated with sofosbuvir (SOF), velpatasvir with or without voxilaprevir (VOX): data from POLARIS 1, 2, 3 and 4

Journal of Hepatology ◽

10.1016/s0168-8278(17)30489-0 ◽

2017 ◽

Vol 66 (1) ◽

pp. S114 ◽

Cited By ~ 1

Author(s):

Z.M. Younossi ◽

M. Stepanova ◽

I. Jacobson ◽

S. Zeuzem ◽

M. Bourliere ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

High Efficacy ◽

Patient Reported ◽

Cirrhotic Patients

499 Ribavirin-Free Regimen With Velpatasvir and Sofosbuvir is Associated With High Efficiency and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From ASTRAL-2 and 3 Clinical Trials

Gastroenterology ◽

10.1016/s0016-5085(16)33500-4 ◽

2016 ◽

Vol 150 (4) ◽

pp. S1035

Author(s):

Zobair M. Younossi ◽

Maria Stepanova ◽

Mark Sulkowski ◽

Graham R. Foster ◽

Nancy Reau ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

High Efficiency ◽

812e The Use of Sofosbuvir and Velpatasvir is Associated With High Efficacy and Improvement in Patient-Reported Outcomes in Patients with Genotype 1, 2, 4, 5 and 6 Chronic Hepatitis C: Results from the ASTRAL-1 Clinical Trial

Gastroenterology ◽

10.1016/s0016-5085(16)34282-2 ◽

2016 ◽

Vol 150 (4) ◽

pp. S1267-S1268 ◽

Cited By ~ 1

Author(s):

Zobair M. Younossi ◽

Maria Stepanova ◽

Jordan Feld ◽

Stefan Zeuzem ◽

Ira M. Jacobson ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

High Efficacy ◽

Faculty Opinions recommendation of Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718344216.793493952 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Outcomes Assessment ◽

Faculty Opinions recommendation of Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718342820.793493549 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Patient Reported ◽

Chronic Hepatitis C Patients

GS-07-Real-world safety, effectiveness, and patient-reported outcomes in patients with chronic hepatitis C virus infection treated with glecaprevir/pibrentasvir: Data from the German Hepatitis C-Registry

Journal of Hepatology ◽

10.1016/s0618-8278(19)30079-9 ◽

2019 ◽

Vol 70 (1) ◽

pp. e45

Author(s):

Markus Cornberg ◽

Albrecht Stoehr ◽

Naumann Uwe ◽

Hartwig Klinker ◽

Lutz Thomas ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Chronic Hepatitis C ◽

Real World ◽

Hepatitis C Virus Infection ◽

Patient Reported ◽

Chronic Hepatitis C Virus

P720 HEALTH-RELATED QUALITY OF LIFE (HRQL) AND PATIENT-REPORTED OUTCOMES (PROS) ASSESSMENT IN CHRONIC HEPATITIS C (CH-C) TREATED WITH SOFOSBUVIR (SOF) AND RIBAVIRIN (RBV): THE VALENCE STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)60882-5 ◽

2014 ◽

Vol 60 (1) ◽

pp. S309

Author(s):

Z.M. Younossi ◽

M. Stepanova ◽

S. Zeuzem ◽

H.W. Reesink ◽

O. Weiland ◽

...

Keyword(s):

Quality Of Life ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Health Related Quality ◽

Patient Reported ◽

Related Quality ◽

Health Related

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

The Journal of Infectious Diseases ◽

10.1093/infdis/jiv005 ◽

2015 ◽

Vol 212 (3) ◽

pp. 367-377 ◽

Cited By ~ 40

Author(s):

Zobair M. Younossi ◽

Maria Stepanova ◽

Mark Sulkowski ◽

Susanna Naggie ◽

Massimo Puoti ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Patient Reported ◽

The Impact

Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues

Expert Review of Gastroenterology & Hepatology ◽

10.1080/17474124.2017.1285227 ◽

2017 ◽

pp. 1-10 ◽

Cited By ~ 4

Author(s):

Fabienne Marcellin ◽

Perrine Roux ◽

Camelia Protopopescu ◽

Martin Duracinsky ◽

Bruno Spire ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Current Knowledge ◽

Direct Acting Antivirals ◽

Patient Reported ◽

Direct Acting